![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 4, 2668-2675, January 28, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Center of Excellence on Neurodegenerative Diseases, Department of Medical Chemistry, Biochemistry, and Biotechnology, University of Milan, 20090 Segrate, Italy
Human fibroblasts, rat neurons, and murine neuroblastoma cells, cultured in the presence of fetal calf serum, were fed with [1-3H]sphingosine to radiolabel sphingolipids. The fate of cell sphingolipids, the release of sphingolipids in the culture medium, the interaction of sphingolipids with the proteins and lipoproteins of fetal calf serum, and the fate of sphingolipids taken up by the cells were investigated. For this latter purpose, the culture medium containing radioactive sphingolipids was delivered to nonlabeled cells. The presence of tritium at position 1 of sphingosine allowed us to follow the extent of sphingolipid catabolism by measuring the production of radioactive phosphatidylethanolamine and proteins by recycling the radioactive ethanolamine formed during sphingosine catabolism and the production of tritiated water. We confirmed that in cells the recycling of sphingosine occurred to a high extent and that only a minor portion of cell sphingolipids was catabolized to the small fragments of ethanolamine and water. Cell sphingolipids were released in the culture medium, where they formed large lipoproteic aggregates at a rate of about 12% per day. Released sphingolipids were taken up by the cells and catabolized to the sphingosine and then to ethanolamine, and recycling of sphingosine was not observed. This suggests that in the presence of fetal calf serum in the culture medium, exogenous sphingolipids directly reach the lysosomes, were they are entirely catabolized. Thus, the trafficking of sphingolipids from cells to the extracellular environment and from this to other cells does not allow the modification of the plasma membrane composition.
Received for publication, July 9, 2004 , and in revised form, November 16, 2004.
* This work was supported by COFIN-PRIN Grants 2002 and 2003, Consiglio Nazionale delle Ricerche (PF Biotechnology), AIRC 2001-2003, FIRST 2002-2003, Italy, and Mizutani Foundation for Glyco-science Grant 2002. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Via Fratelli Cervi 93, 20090 Segrate (Mi). Tel.: 39-02-50330360; Fax: 39-02-0330365; E-mail: Sandro.Sonnino{at}unimi.it.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Giussani, M. Maceyka, H. Le Stunff, A. Mikami, S. Lepine, E. Wang, S. Kelly, A. H. Merrill Jr., S. Milstien, and S. Spiegel Sphingosine-1-Phosphate Phosphohydrolase Regulates Endoplasmic Reticulum-to-Golgi Trafficking of Ceramide. Mol. Cell. Biol., July 1, 2006; 26(13): 5055 - 5069. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Darroch, A. Dagan, T. Granot, X. He, S. Gatt, and E. H. Schuchman A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death J. Lipid Res., November 1, 2005; 46(11): 2315 - 2324. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |